Thank you, Mr. Chair.
Mr. Ouellette, my questions will be for you.
In your opening remarks, you said that, since its creation in 2000, CIHR had invested close to $7 million in Lyme disease research. How does that investment stack up against that of the United States? I assume the Americans do their own share of Lyme disease research. Canada's research resources are always more limited than those of the U.S. Be that as it may, what can we do to enhance the level of international knowledge?
The research is quite targeted. Could you describe for us the North America-wide effort to better understand Lyme disease and the partnerships or agreements you have with American researchers?